What is NDC 83980-031?

83980-031 is the product NDC for etodolac, Etodolac 200 mg/1 capsule, listed with the FDA by Ipca Laboratories Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.

Ipca Laboratories Limited, NDC labeler code 83980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for etodolac?

100 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

etodolac NDC 83980-031 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83980-031Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83980-0031Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
83980-031-01	8398000310183980003101	100 CAPSULE in 1 BOTTLE (83980-031-01)Marketed from Feb 6, 2026
83980-031-05	8398000310583980003105	500 CAPSULE in 1 BOTTLE (83980-031-05)Marketed from Feb 6, 2026
83980-031-13	8398000311383980003113	30 CAPSULE in 1 BOTTLE (83980-031-13)Marketed from Feb 6, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): etodolac
Generic name (nonproprietary): etodolac
Active ingredients: Etodolac — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Ipca Laboratories LimitedNDC labeler code 83980
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 205448
Marketing start: Feb 6, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 83980-031_fa34700b-9acd-4ccf-9e98-0f88e4a35e12SPL ID fa34700b-9acd-4ccf-9e98-0f88e4a35e12SPL set ID d583988c-3e7e-4415-b2fd-34049791cd1cRxCUI 197684, 197685UNII 2M36281008
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483980003101 followed by a unit qualifier and the quantity

Package 83980-0031-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 21, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of etodolac capsules and other treatment options before deciding to use etodolac capsules. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Etodolac capsules are indicated: • For acute and long-term use in the management of signs and symptoms of the following: 1. Osteoarthritis 2. Rheumatoid arthritis • For the management of acute pain

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83980-031

What is NDC 83980-031?: 83980-031 is the product NDC for etodolac, Etodolac 200 mg/1 capsule, listed with the FDA by Ipca Laboratories Limited. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: etodolac.
What is the active ingredient?: Etodolac.
Who is the labeler?: Ipca Laboratories Limited, NDC labeler code 83980. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for etodolac?: 100 other product NDCs are listed under this name. See all etodolac NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other etodolac NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-461	59651-0461-01
Etodolac	Etodolac 500 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-462	59651-0462-01
etodolac	Etodolac 400 mg/1	TabletOral	Ipca Laboratories Limited	83980-029	83980-0029-0183980-0029-1083980-0029-13
etodolac	Etodolac 500 mg/1	TabletOral	Ipca Laboratories Limited	83980-030	83980-0030-0183980-0030-0583980-0030-13
etodolac	Etodolac 300 mg/1	CapsuleOral	A-S Medication Solutions	50090-8037	50090-8037-01
etodolac	Etodolac 300 mg/1	CapsuleOral	Ipca Laboratories Limited	83980-032	83980-0032-0183980-0032-0583980-0032-13
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4542	70518-4542-00
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	Advanced Rx of Tennessee, LLC	80425-0551	80425-0551-01
Etodolac	Etodolac 400 mg/1	Tablet, Film coatedOral	Preferred Pharmaceuticals Inc.	68788-8846	68788-8846-0168788-8846-0268788-8846-03+2 more
Etodolac	Etodolac 500 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4291	70518-4291-00

All 101 etodolac NDCs

Other NDCs under ANDA 205448

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 205448
Product	Strength	Form · route	Labeler	Product NDC
etodolac	Etodolac 300 mg/1	CapsuleOral	A-S Medication Solutions	50090-8037
etodolac	Etodolac 300 mg/1	CapsuleOral	Ipca Laboratories Limited	83980-032